Dermnet Videos
Nonmelanoma skin cancers Videos
- Basal Cell Nevus Syndrome
- Mohs’s Micrographic Surgery
- Sclerosing or Morpheaform Basal Cell Carcinoma
- Skin Cancer Basal Cell Carcinoma
- Skin Cancer Basal Cell Carcinoma Histology
- Skin Cancer Basal Cell Carcinoma Superficial Basal Cell Carcinoma
- Skin Cancer Basal Cell Carcinoma Treatment
- Skin Cancer Nodular Basal Cell Carcinoma
- Skin Cancer Pigmented Basal Cell Carcinoma
- Skin Cancer Cutaneous T-cell Lymphoma Definition and Description
- Skin Cancer Cutaneous T-cell Lymphoma Erythrodermic stage (Sezary syndrome)
- Skin Cancer Cutaneous T-cell Lymphoma Hematology and pathology
- Skin Cancer Cutaneous T-cell Lymphoma Patch Stage
- Skin Cancer Cutaneous T-cell Lymphoma Plaque stage
- Skin Cancer Cutaneous T-cell Lymphoma Stages
- Skin Cancer Cutaneous T-cell Lymphoma Treatment
- Skin Cancer Cutaneous T-cell Lymphoma Tumor stage
- Skin Cancer Squamous Cell Carcinoma
- Skin Cancer Squamous Cell Carcinoma Appearance
- Skin Cancer Squamous Cell Carcinoma Keratoacanthoma Variant
- Skin Cancer Squamous Cell Carcinoma of the Arms and Legs
- Skin Cancer Squamous Cell Carcinoma Relationship to HPV
- Skin Cancer Squamous Cell Carcinoma Transplant Patients
- Skin Cancer Squamous Cell Carcinoma Treatment
Video Topics
Sclerosing or Morpheaform Basal Cell Carcinoma
Morpheaform BCC is an insidious tumor possessing innocuous surface characteristics that can mask its potential for deep, wide extension. The tumor is waxy, firm, flat-to-slightly raised, either pale white or yellowish, and resembles localized scleroderma, thus the designation morpheaform. The borders are indistinct and blend with normal skin. Lesions may become depressed and firm, resembling a scar. The tissue is rigid and difficult or impossible to remove with a curette. Localization of this tumor by inspection or biopsy is impossible. The average subclinical extension beyond clinically delineated borders was 7.2 mm in one study. Treatment consists of wide excision or, preferably, Mohs’ micrographic surgery.